CHRS Stock Analysis: Buy, Sell, or Hold?
CHRS - Coherus Oncology, Inc. Common Stock
$2.16
-0.17 (-7.30%)
▼
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 09, 2026
Get Alerted When CHRS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
11 traders called CHRS this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: CHRS is 7.5% above fair value ($2.01). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: CHRS is 7.5% above fair value ($2.01). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: CHRS is currently trading at $2.16, which is considered extended relative to its 30-day fair value range of $1.32 to $2.01.
Technical Outlook: Technically, CHRS is in a strong uptrend. Immediate support is located at $1.51, while resistance sits at $2.62. Short-term momentum is weak, with the stock down 7.3% recently.
Market Sentiment: CHRS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.75 (+212.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CHRS is in a strong uptrend. Immediate support is located at $1.51, while resistance sits at $2.62. Short-term momentum is weak, with the stock down 7.3% recently.
Market Sentiment: CHRS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $6.75 (+212.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$1.32 -
$2.01
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
Protect Your Profits
Holding CHRS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+7.5% above fair value)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.3%)
- BULLISH: Trading 212.5% below Wall St target ($6.75)
Fair Price Analysis
30-Day Fair Range
$1.32 -
$2.01
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$1.51
Resistance Level
$2.62
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-4.41
Wall Street Target
$6.75
(+212.5%)
Revenue Growth (YoY)
91.2%
Earnings Growth (YoY)
-75.5%
Profit Margin
55.8%
Last updated: February 01, 2026 8:10 AM ET
Data refreshes hourly during market hours. Next update: 9:10 AM
Data refreshes hourly during market hours. Next update: 9:10 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CHRS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 54 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$486 | 45 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$500 | 62 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$91 | 64 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$830 | 52 HOLD |
Advanced CHRS Option Strategies
Professional options setups generated by AI based on today's CHRS price and gamma walls.
